前循环卒中发病超6小时的血栓切除术(AURORA):系统综述与个体患者数据Meta分析
AURORA协作组对6项随机对照试验的505例前循环近端大血管闭塞卒中患者进行个体数据Meta分析,比较血栓切除术与单纯最佳药物治疗。90天改良Rankin量表分析显示血栓切除获益(未校正共同OR 2.42,95%CI 1.76-3.33;校正后OR 2.54,95%CI 1.83-3.54),功能独立率45.9% vs 19.3%,90天死亡率和症状性颅内出血无显著差异,12-24小时随机化者疗效更强(共同OR 5.86 vs 6-12小时1.76,交互P=0.0087)。
要点
- 发病6-24小时前循环大血管闭塞卒中,血栓切除术改善90天改良Rankin量表评分(校正共同OR 2.54,95%CI 1.83-3.54)。
- 血栓切除组功能独立(mRS 0-2)45.9%(122/266) vs 单纯最佳药物治疗组19.3%(46/238),p<0.0001。
- 90天死亡率16.5%(44/266) vs 19.3%(46/238)、症状性颅内出血5.3%(14/266) vs 3.3%(8/239),均无显著差异。
核心结论
- 研究结果强化了发病6-24小时时间窗内有可逆性脑缺血证据的患者行血管内血栓切除术获益的证据,并与临床实践相关。
- 作者认为,在这些患者中不应根据就诊方式或6-24小时时间窗内的就诊时间点而不予血栓切除术。
研究设计与样本
- 研究类型为系统综述与个体患者数据Meta分析,检索2010年1月1日至2021年3月1日期间的血管内卒中治疗随机对照试验。
- 从17项筛选的已发表随机试验中纳入6项符合标准的试验,共505例患者(干预组266例,对照组239例;平均年龄68.6岁(SD 13.7),女性259例(51.3%))。
- 主要结局为90天改良Rankin量表(mRS)残疾程度,采用序贯逻辑回归分析;关键安全性结局为90天症状性颅内出血和死亡率。
主要发现
- 主要结局分析显示血栓切除获益,未校正共同OR为2.42(95%CI 1.76-3.33;p<0.0001),校正年龄、性别、基线卒中严重程度、基线头颅CT梗死范围及从发病到随机化时间的共同OR为2.54(95%CI 1.83-3.54;p<0.0001)。
- 血栓切除组日常生活活动独立(mRS 0-2)率为45.9%(122/266),高于单纯最佳药物治疗组的19.3%(46/238),p<0.0001。
- 90天死亡率干预组16.5%(44/266) vs 对照组19.3%(46/238),症状性颅内出血干预组5.3%(14/266) vs 对照组3.3%(8/239),两组均无显著差异。
- 按年龄、性别、基线卒中严重程度、血管闭塞部位、基线Alberta卒中项目早期CT评分及就诊方式定义的亚组间未见治疗效应异质性。
- 12-24小时随机化者的治疗效应强于6-12小时随机化者(共同OR 5.86(95%CI 3.14-10.94) vs 1.76(95%CI 1.18-2.62);交互作用p=0.0087)。
临床怎么用
- 作者认为,对于有可逆性脑缺血证据且处于6-24小时时间窗的患者,不应根据就诊方式或时间窗内就诊时间点而不予血栓切除术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Trials examining the benefit of thrombectomy in anterior circulation proximal large vessel occlusion stroke have enrolled patients considered to have salvageable brain tissue, who were randomly assigned beyond 6 h and (depending on study protocol) up to 24 h from time last seen well. We aimed to estimate the benefit of thrombectomy overall and in prespecified subgroups through individual patient data meta-analysis. METHODS: We did a systematic review and individual patient data meta-analysis between Jan 1, 2010, and March 1, 2021, of randomised controlled trials of endovascular stroke therapy. In the Analysis Of Pooled Data From Randomized Studies Of Thrombectomy More Than 6 Hours After Last Known Well (AURORA) collaboration, the primary outcome was disability on the modified Rankin Scale (mRS) at 90 days, analysed by ordinal logistic regression. Key safety outcomes were symptomatic intracerebral haemorrhage and mortality within 90 days. FINDINGS: Patient level data from 505 individuals (n=266 intervention, n=239 control; mean age 68·6 years [SD 13·7], 259 [51·3%] women) were included from six trials that met inclusion criteria of 17 screened published randomised trials. Primary outcome analysis showed a benefit of thrombectomy with an unadjusted common odds ratio (OR) of 2·42 (95% CI 1·76-3·33; p<0·0001) and an adjusted common OR (for age, gender, baseline stroke severity, extent of infarction on baseline head CT, and time from onset to random assignment) of 2·54 (1·83-3·54; p<0·0001). Thrombectomy was associated with higher rates of independence in activities of daily living (mRS 0-2) than best medical therapy alone (122 [45·9%] of 266 vs 46 [19·3%] of 238; p<0·0001). No significant difference between intervention and control groups was found when analysing either 90-day mortality (44 [16·5%] of 266 vs 46 [19·3%] of 238) or symptomatic intracerebral haemorrhage (14 [5·3%] of 266 vs eight [3·3%] of 239). No heterogeneity of treatment effect was noted across subgroups defined by age, gender, baseline stroke severity, vessel occlusion site, baseline Alberta Stroke Program Early CT Score, and mode of presentation; treatment effect was stronger in patients randomly assigned within 12-24 h (common OR 5·86 [95% CI 3·14-10·94]) than those randomly assigned within 6-12 h (1·76 [1·18-2·62]; pinteraction=0·0087). INTERPRETATION: These findings strengthen the evidence for benefit of endovascular thrombectomy in patients with evidence of reversible cerebral ischaemia across the 6-24 h time window and are relevant to clinical practice. Our findings suggest that in these patients, thrombectomy should not be withheld on the basis of mode of presentation or of the point in time of presentation within the 6-24 h time window. FUNDING: Stryker Neurovascular.
引用
- Jovin TG, Nogueira RG, Lansberg MG, et al. Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis. Lancet. 2021. PMID: 34774198. doi:10.1016/S0140-6736(21)01341-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。